ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/03/2021
Back to search
Official data from USPTO
DNDI DRUGS FOR NEGLECTED DISEASES INITIATIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
09/03/2021
Trademark type
Combined
Nice classes
36, 41, 42
Filing date
04/25/2008
Registration date
04/07/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2019
Last transaction
01/02/2019
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
12
Owner location
CH
Examiner
LEE, DEBRA
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
D. I. (pessoa física)
Drugs for Neglected Diseases initiative; (DNDi)
Representatives
Glenn A. Gundersen Dechert LLP
Technical classification
Nice Classes
Class 36Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Financial servicesfinancial managementcash-flow management and currency ex-change; financial research services for otherssearching for charitable funding for medical and scientific research and development
Class 41
Educationraising public awarenessparticularly by awakening it to the importance of neglected diseases and attesting to the true actual facts concerning lack of treatmentin order to promote medical and scientific research and development in the field of neglected diseases
Class 42
Drug development for neglected diseaseslittle known to the publicin particular sleeping sicknessChagas' disease and leishmaniasis
Publications
History of USPTO decisions and trademark events.
42 publications found
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/01/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/12/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
09/12/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/02/2019
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/02/2019
71AG
REGISTERED-SEC.71 ACCEPTED
01/02/2019
ES71
TEAS SECTION 71 RECEIVED
12/04/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/17/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/07/2018
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/07/2015
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
04/07/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2015
ES75
TEAS SECTION 71 & 15 RECEIVED
03/27/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/07/2013
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/14/2011
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/27/2009
FIMP
FINAL DISPOSITION PROCESSED
07/27/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/08/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2009
PUBO
PUBLISHED FOR OPPOSITION
01/20/2009
NPUB
NOTICE OF PUBLICATION
12/31/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/17/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/02/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2008
PAPER RECEIVED
11/26/2008
FAXX
FAX RECEIVED
11/20/2008
NAUD
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
11/03/2008
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
10/31/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/17/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2008
ALIE
ASSIGNED TO LIE
10/16/2008
PAPER RECEIVED
09/30/2008
RFNT
REFUSAL PROCESSED BY IB
09/04/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/19/2008
RFRR
REFUSAL PROCESSED BY MPU
08/19/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/19/2008
CNRT
NON-FINAL ACTION WRITTEN
08/18/2008
DOCK
ASSIGNED TO EXAMINER
08/11/2008
NWAP
NEW APPLICATION ENTERED
05/30/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/29/2008
Continuous trademark protection
Get notified about every new filing that threatens DNDI DRUGS FOR NEGLECTED DISEASES INITIATIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.